Skip to content
Subscriber Only
Business
Prognosis

Novartis Joins Effort to Vet Malaria Drug Hydroxychloroquine for Coronavirus

  • Drugmaker aims to have study results as soon as early summer
  • Novartis: hydroxychloroquine question needs to be answered
Video player cover image
Do We Already Have the Cure for Covid-19?
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Novartis AG will run a U.S. study of the malaria drug hydroxychloroquine for Covid-19, the latest effort to determine whether the hyped medicine can help in the battle against the pandemic.